Solutions

Device Manufacturers

The challenge

Medical device manufacturers provide high quality imaging solutions for clinical assessment. While imaging capability is strong, clinical workflows can be enriched with automated AI, or services expanded to provide clinical decision support workflows.

the solution

RetinAI has certified AI solutions that provide automated analysis across disparate imaging datasets. Clinics can continue to use the imaging platforms they prefer, while benefiting from enhanced imaging capabilities for accelerating clinical studies, choosing treatments or monitoring outcomes.

Use cases for Device Manufacturers

Device & Data Connectivity

RetinAI can provide a certified data management and AI software platform to integrate additional imaging devices within a clinical setting.  

The platform is an open format that can connect to medical device manufacturers’ platform via API calls or via an existing PACS.

Value-add for Clinics (AI)

RetinAI has commercially-ready AI models to enhance imaging solutions already provided by manufacturers.  

The AI is a value-add that medical device manufacturers can offer to clinics.

RetinAI’s certified AI can support patient identification for clinical studies or support physicians to assess outcomes based on retinal biomarkers, retinal fluid and OCT layer analysis.

Interested in learning more?

*Disclaimer

RetinAI Discovery is a CE-marked medical device according to the Medical Devices Regulation (EU) 2017/745
and the AI models are CE-marked devices according to Medical Devices Directive 93/42/EEC
RetinAI Discovery® is a 510(k) FDA Cleared medical device in US.
RetinAI Discovery® and Retinai® are both trademarks of RetinAI Medical AG.

Discovery and AI Models are CE-Marked medical devices since April 2020 & December 2020 respectively.